Literature DB >> 24243012

An integrated overview of HIV-1 latency.

Debbie S Ruelas1, Warner C Greene.   

Abstract

Despite significant advances in our understanding of HIV, a cure has not been realized for the more than 34 million infected with this virus. HIV is incurable because infected individuals harbor cells where the HIV provirus is integrated into the host's DNA but is not actively replicating and thus is not inhibited by antiviral drugs. Similarly, these latent viruses are not detected by the immune system. In this Review, we discuss HIV-1 latency and the mechanisms that allow this pathogenic retrovirus to hide and persist by exploiting the cellular vehicles of immunological memory.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24243012      PMCID: PMC4361081          DOI: 10.1016/j.cell.2013.09.044

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  100 in total

1.  Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells.

Authors:  Sergei Popov; Agnès-Laurence Chenine; Andreas Gruber; Pei-Lin Li; Ruth M Ruprecht
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

Authors:  Richard E Nettles; Tara L Kieffer; Patty Kwon; Daphne Monie; Yefei Han; Teresa Parsons; Joseph Cofrancesco; Joel E Gallant; Thomas C Quinn; Brooks Jackson; Charles Flexner; Kathryn Carson; Stuart Ray; Deborah Persaud; Robert F Siliciano
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Decay characteristics of HIV-1-infected compartments during combination therapy.

Authors:  A S Perelson; P Essunger; Y Cao; M Vesanen; A Hurley; K Saksela; M Markowitz; D D Ho
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

5.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription.

Authors:  M K Lewinski; D Bisgrove; P Shinn; H Chen; C Hoffmann; S Hannenhalli; E Verdin; C C Berry; J R Ecker; F D Bushman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells.

Authors:  S Kinoshita; B K Chen; H Kaneshima; G P Nolan
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  SIRT1 regulates HIV transcription via Tat deacetylation.

Authors:  Sara Pagans; Angelika Pedal; Brian J North; Katrin Kaehlcke; Brett L Marshall; Alexander Dorr; Claudia Hetzer-Egger; Peter Henklein; Roy Frye; Michael W McBurney; Henning Hruby; Manfred Jung; Eric Verdin; Melanie Ott
Journal:  PLoS Biol       Date:  2005-02-08       Impact factor: 8.029

View more
  152 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Implication of cell-in-cell structures in the transmission of HIV to epithelial cells.

Authors:  Chao Ni; Lei Huang; Yuhui Chen; Meifang He; Yazhuo Hu; Siyang Liu; Xiangdong Fang; Jingyun Li; Qiang Sun; Xiaoning Wang
Journal:  Cell Res       Date:  2015-10-02       Impact factor: 25.617

3.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

4.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.

Authors:  Zhangping He; Shuliang Jing; Tao Yang; Jingliang Chen; Feng Huang; Wanying Zhang; Zhilin Peng; Bingfeng Liu; Xiancai Ma; Liyang Wu; Ting Pan; Xu Zhang; Linghua Li; Weiping Cai; Xiaoping Tang; Junsong Zhang; Hui Zhang
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

6.  A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2.

Authors:  Kyle D Pedro; Luis M Agosto; Jared A Sewell; Kimberly A Eberenz; Xianbao He; Juan I Fuxman Bass; Andrew J Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

7.  Position effects influence HIV latency reversal.

Authors:  Heng-Chang Chen; Javier P Martinez; Eduard Zorita; Andreas Meyerhans; Guillaume J Filion
Journal:  Nat Struct Mol Biol       Date:  2016-11-21       Impact factor: 15.369

Review 8.  Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.

Authors:  Maxime J Jean; Guillaume Fiches; Tsuyoshi Hayashi; Jian Zhu
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-12       Impact factor: 2.205

9.  Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.

Authors:  Kevin B Einkauf; Guinevere Q Lee; Ce Gao; Radwa Sharaf; Xiaoming Sun; Stephane Hua; Samantha My Chen; Chenyang Jiang; Xiaodong Lian; Fatema Z Chowdhury; Eric S Rosenberg; Tae-Wook Chun; Jonathan Z Li; Xu G Yu; Mathias Lichterfeld
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

Review 10.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.